
Publications
NAR Cancer
Loss of ribosomal protein uL14 enables tumor escape from T cell immunosurveillance
Dopler, A., Kyei-Baffour, E.S., Kerkhoff, M., Alkan, F., Malka, Y., Hoefakker, K., van der Kammen, R., Hoekman, L., Bleijerveld, O., Bradaric, A., et al. (2025).
Immunity
Adoptive T-cell therapy targeting a broadly shared, inducible product of aberrant mRNA translation
Champagne J, Nielsen MM, Feng X, Montenegro Navarro J, Pataskar A, Voogd R, Giebel L, Nagel R, Berenst N, Fumagalli A, Kochavi A, Lovecchio D, Valcanover L, Malka Y, Yang W, Laos M, Li Y, Proost N, van de Ven M, van Tellingen O, Bleijerveld OB, Haanen JBAG, Olweus J, Agami R. (2024).
Nucleic Acids Res.
Kochavi, A., Nagel, R., Körner, P.R., Bleijerveld, O., Lin, C.P., Huinen, Z., Malka, Y., Proost, N., van de Ven, M., Feng, X., Montenegro N.J., Pataskar, A., Peeper, D., Champagne, J., Agami, R. (2024)
P-stalk ribosomes act as master regulators of cytokine-mediated processes
Dopler, A., Alkan, F., Malka, Y., Hoefakker, K., Isaeva, O., Kerkhoff, M., Gangaev, A., Silva, J., Ramalho, S., Van der Kammen, R., Kok, M., Yewdel, J., Kvistborg, P., Faller W.J. P-stalk ribosomes act as master regulators of cytokine-mediated processes. (2024)
Cell
Science
DNA damage induces TP53-independent apoptosis through TTA-codon ribosome stalling
Boon, N.J., Kochavi, A., Mertens, S., Körner, P.R., Malka, Y., Van der Horst, S., Draper, J.M., Wessels, L.F.A., Haahr, P., Snippert, H.J., Agami R and Brummelkamp T.R. 2024.
Cancer Cell
Multimodal stimulation screens reveal unique and shared genes limiting T-cell fitness
Lin, C.P., Levy P., Alflen, A., Apriamashvili, G., Ligtenberg, M., Vredevoogd, D.W., Bleijerveld, O., Alkan, F., Malka, Y., Hoekman, L., Markovits, E., Traets, J.J.H., George, A., Krijgsman, O., Van Vliet, A., De Bruijn, B., Van Hal-van Veen, S., Visser, N.L., Van der Helm, P., Gomez, J.D., Warda, H., Behrens, L., Mardesic, P., Dehni, B., Markel, G., Faller, W.J., Altelaar, M., Agami, R., Besser, M.J., Peeper, D.S. (2024)
BioRxiv
(Under Revision)
RNA dicing regulates the expression of an oncogenic JAK1 isoform
Van der Kammen, R., Ju, S., Alkan, F., Lee, C., Faller, W.J., Malka, Y. (2024).
J Exp Med.
MYC is a clinically significant determinant of mTOR inhibitor resistance in breast cancer
Bhin, J., Yemelyanenko, J., Chao, X., Klarenbeek, S., Opdam, M., Malka, Y., Hoekman, L., Kruger, D., Bleijerveld, O., Brambillasca, C.S., Sprengers, J., Siteur, B., Annunziato, S., Van Haren, M.J., Martin, N.I., Van de Ven, N., Peters, D., Agami, R., Linn, S.C., Boven, E., Altelaar, M., Jonkers, J., Zingg, D. and Wessels, L.F.A. (2023).
Molecular Cell
Malka, Y., Alkan, F., Ju, S., Körner, P.R., Pataskar, A., Shulman, E., Loayza-Puch, F., Champagne, J., Wenzel, C., Faller, W.J., Elkon, R., Lee, C., Agami, R. (2022).
Research Highlight on this paper: Heinke, L. Exploring the uncharted landscape of truncated mRNAs. Nat Rev Mol Cell Biol . https://doi.org/10.1038/s41580-022-00561-z. (2022)
Nature Comm.
Malka, Y., Steiman-Shimony, A., Rosenthal, E., Argaman, L., Cohen-Daniel, L., Arbib, E., Margalit, H., Kaplan, T., and Berger, M. (2017).
PLoS Genet.
Weiss, R., Bartok, O., Mezan, S., Malka, Y., and Kadener, S. (2014).
Cytometry Part A
Analysis of apoptosis in FUCCI HeLa cells
Malka, Y., and Eden, S. (2011).
